ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103. A total of 26 filers reported holding ENTASIS THERAPEUTICS HLDGS I in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $122,000 | -52.5% | 49,478 | -60.7% | 0.00% | – |
Q3 2020 | $257,000 | +40.4% | 125,848 | +342.8% | 0.00% | – |
Q2 2019 | $183,000 | -13.3% | 28,419 | -9.1% | 0.00% | – |
Q1 2019 | $211,000 | +51.8% | 31,250 | -8.5% | 0.00% | – |
Q4 2018 | $139,000 | -83.9% | 34,143 | -57.0% | 0.00% | -100.0% |
Q3 2018 | $864,000 | – | 79,437 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GARDNER LEWIS ASSET MANAGEMENT L P | 1,249,778 | $2,750,000 | 0.55% |
Beryl Capital Management LLC | 1,131,772 | $2,490,000 | 0.26% |
DELTEC ASSET MANAGEMENT LLC | 155,614 | $342,000 | 0.08% |
Knott David M Jr | 41,700 | $92,000 | 0.04% |
TPG GP A, LLC | 1,020,748 | $2,246,000 | 0.04% |
GABELLI & Co INVESTMENT ADVISERS, INC. | 40,900 | $90,000 | 0.01% |
Ergoteles LLC | 135,323 | $298,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 132,600 | $292,000 | 0.01% |
Virtu Financial LLC | 20,027 | $44,000 | 0.00% |
GABELLI FUNDS LLC | 59,100 | $130,000 | 0.00% |